Kansuk İlaç was established in 2017 on 4,000 m2 area in Yassıören Akpınar Organized Industrial Zone to manufacture human use products, leukocyte filters, and blood bags by using advanced production technologies. In 2019, the facility started to operate on 10,500 m2 closed area.
ISO 13485:2016 Medical Devices Quality Management System
G.M.P. (Good Manufacturing Practices) Certificate
Human products (Ovule, Suppositories, Powder Chassis) and Medical products (Sterile Blood Bags, Sterile Blood Transfusion Sets, Production, Design and Development of Sterile Leukacid Filter Sets) production requirements of “Current Good Manufacturing Practices (cGMP)”, “Current Good Laboratory Practices (cGLP)” and “ISO 13485:2016 Medical Device Quality Management Systems” are met at the highest level.
Kansuk continues to be the pioneer of the Turkish Pharmaceutical Industry with its professional and expert staff. We ensure business continuity by applying high-level Environmental and Occupational Safety rules in all processes in our production facility.
We use the most up-to-date technologies, the principle of maximum efficiency with minimum cost is adopted. We continue to be the pioneer in the field with continuous improvement and development studies.
We protect our employees' health, keep our environment clean, and fulfil our legal responsibilities with all our units to ensure machinery and equipment safety due to our tremendous respect for the environment and people. By this means, we maximize our business continuity and efficiency.
We fill a significant gap in the Turkish and international medical device and human use markets with our facility with an annual production capacity of 65 million human use products and 2 million set sterile medical product. Our products are sold in 23 countries around the world.
|Blood Bag:||1.000.000 sets/year|
|Sets with Leukocyte Filter:||1.000.000 sets/year|
|Total:||17.000.00 units are produced.*|
Our company, which is the first and only blood bag manufacturer in Turkey, has become a specialist in blood thanks to its long years of experience in this field and the distributorships it has received from many well-known companies around the world in recent years. In this way, it continues to operate in all areas, from blood collection to its components, blood products processing, and turnkey blood projects.
It supports donor acquisition programs, training programs for services using blood and blood components and functioning blood centres, and institutions and associations working on these issues to develop the market and raise standards.